Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""M3 Muscarinic receptor"" wg kryterium: Wszystkie pola


Tytuł:
Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity.
Autorzy:
Mansfield KJ; Department of Physiology and Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, Australia.
Liu L
Moore KH
Vaux KJ
Millard RJ
Burcher E
Pokaż więcej
Źródło:
BJU international [BJU Int] 2007 Jun; Vol. 99 (6), pp. 1433-8.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Muscarinic Antagonists/*pharmacology
Receptor, Muscarinic M2/*metabolism
Receptor, Muscarinic M3/*metabolism
Urinary Bladder, Overactive/*metabolism
Actins/metabolism ; Adult ; Aged ; Aged, 80 and over ; Biopsy/methods ; Case-Control Studies ; Female ; Humans ; Middle Aged ; Mucous Membrane/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Urinary Bladder/metabolism ; Urinary Bladder/pathology ; Urinary Bladder, Overactive/drug therapy ; Urinary Bladder, Overactive/etiology ; Urinary Bladder, Overactive/pathology
Czasopismo naukowe
Tytuł:
ADME properties of CHF6366, a novel bi-functional M3 muscarinic receptor antagonist and ß2 adrenoceptor agonist (MABA) radiolabelled at both functional moieties.
Autorzy:
Ghiglieri, Alberto (AUTHOR)
Messina, Monica (AUTHOR)
Cenacchi, Valentina (AUTHOR)
Piutti, Claudia (AUTHOR)
Cinato, Flavio (AUTHOR)
Brogin, Giandomenico (AUTHOR)
Puccini, Paola (AUTHOR)
Pokaż więcej
Źródło:
Xenobiotica. Apr2023, Vol. 53 Issue 4, p288-308. 21p.
Czasopismo naukowe
Tytuł:
Muscarinic M 3 positive allosteric modulator ASP8302 enhances bladder contraction and improves voiding dysfunction in rats.
Autorzy:
Okimoto R; Drug Discovery Research, Astellas Pharma Inc, Ibaraki, Japan.
Ino K; Drug Discovery Research, Astellas Pharma Inc, Ibaraki, Japan.
Ishizu K; Drug Discovery Research, Astellas Pharma Inc, Ibaraki, Japan.
Takamatsu H; Drug Discovery Research, Astellas Pharma Inc, Ibaraki, Japan.
Sakamoto K; Drug Discovery Research, Astellas Pharma Inc, Ibaraki, Japan.
Yuyama H; Drug Discovery Research, Astellas Pharma Inc, Ibaraki, Japan.
Imazumi K; Drug Discovery Research, Astellas Pharma Inc, Ibaraki, Japan.
Ohtake A; Drug Discovery Research, Astellas Pharma Inc, Ibaraki, Japan.
Masuda N; Drug Discovery Research, Astellas Pharma Inc, Ibaraki, Japan.
Takeda M; Drug Discovery Research, Astellas Pharma Inc, Ibaraki, Japan.
Pokaż więcej
Źródło:
Lower urinary tract symptoms [Low Urin Tract Symptoms] 2022 Jul; Vol. 14 (4), pp. 289-300. Date of Electronic Publication: 2022 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Muscarinic Agonists*/pharmacology
Muscarinic Antagonists*/pharmacology
Receptor, Muscarinic M3*/physiology
Urinary Bladder*
Animals ; Muscle Contraction ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł:
Sialorrhea Successfully Treated by the Combined Use of Selective M1 and M3 Muscarinic Acetylcholine Receptor Antagonists.
Autorzy:
Yamamura Y; Department of Otolaryngology, Tokyo Women's Medical University.
Nonaka M; Department of Otolaryngology, Tokyo Women's Medical University.
Pokaż więcej
Źródło:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2019; Vol. 86 (2), pp. 117-121.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Muscarinic Antagonists/*administration & dosage
Pirenzepine/*administration & dosage
Receptor, Muscarinic M1/*antagonists & inhibitors
Receptor, Muscarinic M3/*antagonists & inhibitors
Sialorrhea/*drug therapy
Solifenacin Succinate/*administration & dosage
Animals ; Drug Therapy, Combination ; Humans ; Male ; Mice, Knockout ; Middle Aged ; Radionuclide Imaging ; Receptor, Muscarinic M1/physiology ; Receptor, Muscarinic M3/physiology ; Salivary Glands/diagnostic imaging ; Salivary Glands/physiopathology ; Salivation ; Sialorrhea/diagnostic imaging ; Sialorrhea/physiopathology ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Central muscarinic receptor subtypes (M1 and M3) involved in carbacol-induced hypophagia in neonatal broiler chicken.
Autorzy:
Zendehdel M; Section of Physiology, Department of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Lankarani Mohajer L; Section of Physiology, Department of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Hassanpour S; Section of Physiology, Department of Basic Sciences, Faculty of Veterinary Medicine, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Pokaż więcej
Źródło:
The International journal of neuroscience [Int J Neurosci] 2020 Feb; Vol. 130 (2), pp. 204-211. Date of Electronic Publication: 2019 Oct 02.
Typ publikacji:
Journal Article
MeSH Terms:
Behavior, Animal/*drug effects
Carbachol/*pharmacology
Eating/*drug effects
Muscarinic Agonists/*pharmacology
Muscarinic Antagonists/*pharmacology
Receptor, Muscarinic M1/*drug effects
Receptor, Muscarinic M3/*drug effects
Animals ; Animals, Newborn ; Carbachol/administration & dosage ; Chickens ; Disease Models, Animal ; Injections, Intraventricular ; Muscarinic Agonists/administration & dosage ; Muscarinic Antagonists/administration & dosage ; Piperidines/pharmacology ; Pirenzepine/analogs & derivatives ; Pirenzepine/pharmacology ; Receptor, Muscarinic M1/agonists ; Receptor, Muscarinic M1/antagonists & inhibitors ; Receptor, Muscarinic M3/agonists ; Receptor, Muscarinic M3/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
In vitro functional interactions of acetylcholine esterase inhibitors and muscarinic receptor antagonists in the urinary bladder of the rat.
Autorzy:
Killi UK; Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Kralove, Czech Republic.
Wsol V
Soukup O
Kuca K
Winder M
Tobin G
Pokaż więcej
Źródło:
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2014 Feb; Vol. 41 (2), pp. 139-46.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cholinesterase Inhibitors/*pharmacology
Heart Atria/*drug effects
Muscarinic Antagonists/*pharmacology
Receptor, Muscarinic M2/*antagonists & inhibitors
Receptor, Muscarinic M3/*antagonists & inhibitors
Urinary Bladder/*drug effects
Animals ; Atropine/pharmacology ; Diamines/pharmacology ; Dose-Response Relationship, Drug ; Heart Atria/enzymology ; Heart Atria/metabolism ; In Vitro Techniques ; Male ; Methacholine Chloride/pharmacology ; Muscle Contraction/drug effects ; Obidoxime Chloride/pharmacology ; Physostigmine/pharmacology ; Rats ; Receptor Cross-Talk ; Urinary Bladder/enzymology ; Urinary Bladder/metabolism
Czasopismo naukowe
Tytuł:
Pharmacokinetics, safety and tolerability of Bencycloquidium bromide, a novel selective muscarinic M1/M3 receptor antagonist, after single and multiple intranasal doses in healthy chinese subjects: an open-label, single-center, first-in-human study.
Autorzy:
Sun L; China Pharmaceutical University, Nanjing, China.
Ding L
Wang Y
Zhou W
Yan Z
Sun W
Zhang H
Ou N
Chen X
Pokaż więcej
Źródło:
Drugs in R&D [Drugs R D] 2012 Mar 01; Vol. 12 (1), pp. 17-28.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Bridged Bicyclo Compounds, Heterocyclic/*adverse effects
Bridged Bicyclo Compounds, Heterocyclic/*pharmacokinetics
Muscarinic Antagonists/*adverse effects
Muscarinic Antagonists/*pharmacokinetics
Receptor, Muscarinic M1/*antagonists & inhibitors
Receptor, Muscarinic M3/*antagonists & inhibitors
Administration, Intranasal ; Adult ; Bridged Bicyclo Compounds, Heterocyclic/administration & dosage ; Bridged Bicyclo Compounds, Heterocyclic/blood ; China ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged ; Molecular Structure ; Muscarinic Antagonists/administration & dosage ; Muscarinic Antagonists/blood ; Young Adult
Czasopismo naukowe
Tytuł:
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor.
Autorzy:
Dowling MR; Novartis Institutes for Biomedical Research, Wimblehurst Road, Horsham, West Sussex RH12 5AB. />Charlton SJ
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2006 Aug; Vol. 148 (7), pp. 927-37. Date of Electronic Publication: 2006 Jul 10.
Typ publikacji:
Journal Article
MeSH Terms:
Muscarinic Antagonists/*metabolism
Muscarinic Antagonists/*pharmacology
Receptor, Muscarinic M3/*drug effects
Receptor, Muscarinic M3/*metabolism
Algorithms ; Animals ; Atropine/pharmacology ; Binding, Competitive/drug effects ; CHO Cells ; Cell Membrane/drug effects ; Cell Membrane/metabolism ; Cricetinae ; Indicators and Reagents ; Kinetics ; Ligands ; N-Methylscopolamine/metabolism ; N-Methylscopolamine/pharmacology ; Radioligand Assay ; Scopolamine Derivatives/pharmacology ; Tiotropium Bromide
Czasopismo naukowe
Tytuł:
Agonist and antagonist sensitivity of non-selective cation channel currents evoked by muscarinic receptor stimulation in bovine ciliary muscle cells.
Autorzy:
Sugawara R; Department of Ophthalmology, Asahikawa Medical College, Midorigaoka-Higashi 2-1-1-1, Asahikawa 078-8510, Hokkaido, Japan.
Takai Y
Miyazu M
Ohinata H
Yoshida A
Takai A
Pokaż więcej
Źródło:
Autonomic & autacoid pharmacology [Auton Autacoid Pharmacol] 2006 Jul; Vol. 26 (3), pp. 285-92.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ciliary Body/*drug effects
Muscarinic Agonists/*pharmacology
Muscarinic Antagonists/*pharmacology
Receptor, Muscarinic M3/*drug effects
TRPC Cation Channels/*drug effects
Animals ; Atropine/pharmacology ; Barium ; Carbachol/pharmacology ; Cattle ; Cells, Cultured ; Ciliary Body/chemistry ; Ciliary Body/metabolism ; Dose-Response Relationship, Drug ; Membrane Potentials/drug effects ; Microscopy, Fluorescence ; Muscle Cells/drug effects ; Patch-Clamp Techniques ; Piperidines/pharmacology ; Pirenzepine/pharmacology ; Receptor, Muscarinic M3/metabolism ; TRPC Cation Channels/metabolism
Czasopismo naukowe
Tytuł:
Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers.
Autorzy:
Kay GG; Washington Neuropsychological Institute, Washington, DC 20008, USA. />Wesnes KA
Pokaż więcej
Źródło:
BJU international [BJU Int] 2005 Nov; Vol. 96 (7), pp. 1055-62.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Benzofurans/*pharmacology
Cognition/*drug effects
Muscarinic Antagonists/*pharmacology
Pyrrolidines/*pharmacology
Receptor, Muscarinic M3/*antagonists & inhibitors
Urinary Incontinence/*drug therapy
Adult ; Benzofurans/therapeutic use ; Cross-Over Studies ; Dicyclomine/therapeutic use ; Double-Blind Method ; European Union ; Humans ; Male ; Muscarinic Antagonists/therapeutic use ; Pyrrolidines/therapeutic use ; Salivation/drug effects ; Signal Processing, Computer-Assisted ; Time Factors ; Urinary Incontinence/psychology
Czasopismo naukowe
Tytuł:
Bis-Quinolinium Cyclophane Blockers of SK Potassium Channels Are Antagonists of M3 Muscarinic Acetylcholine Receptors.
Autorzy:
Bugay, Vladislav
Wallace, Derek J.
Wang, Bin
Salinas, Irving
Chapparo, Adriana Paola
Smith, Hudson Ryan
Dube, Peter Herbert
Brooks, Edward G.
Berg, Kelly Ann
Brenner, Robert
Pokaż więcej
Temat:
POTASSIUM antagonists
MUSCARINIC acetylcholine receptors
MUSCARINIC antagonists
CHOLINERGIC receptors
MUSCARINIC receptors
CHO cell
POTASSIUM channels
Źródło:
Frontiers in Pharmacology; 9/16/2020, Vol. 11, pN.PAG-N.PAG, 12p
Czasopismo naukowe
Tytuł:
Effects of combined treatment with fesoterodine and mirabegron in a pelvic congestion rat model: Results from in vitro and in vivo functional studies.
Autorzy:
Sugaya, Kimio (AUTHOR)
Yamagami, Hidetomi (AUTHOR)
Nishijima, Saori (AUTHOR)
Kadekawa, Katsumi (AUTHOR)
Hizue, Masanori (AUTHOR)
Ito, Yoshihiko (AUTHOR)
Yamada, Shizuo (AUTHOR)
Pokaż więcej
Źródło:
LUTS. May2020, Vol. 12 Issue 2, p173-179. 7p.
Czasopismo naukowe
Tytuł:
Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder.
Autorzy:
Esin, Ece (AUTHOR)
Ergen, Ali (AUTHOR)
Cankurtaran, Mustafa (AUTHOR)
Yavuz, Burcu Balam (AUTHOR)
Halil, Meltem (AUTHOR)
Ulger, Zekeriya (AUTHOR)
Yeşil, Yusuf (AUTHOR)
Kuyumcu, Mehmet Emin (AUTHOR)
Ozcan, Munevver (AUTHOR)
Cankurtaran, Eylem (AUTHOR)
Ariogul, Servet (AUTHOR)
Pokaż więcej
Źródło:
Aging & Mental Health. Mar2015, Vol. 19 Issue 3, p217-223. 7p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies